Mylan Institutional LLC et al v. Aurobindo Pharma Ltd et al, No. 2:16-cv-00491 (E.D. Tex. Feb. 7, 2017)
From the Opinion
The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.
Before the Court is the Report and Recommendation (Docket No. 101) filed by Magistrate Judge Payne on November 21, 2016 recommending th at Plaintiffs’ motion for a preliminary injunction (Docket No. 20) be granted. Au robindo objects to the Re port and Recommendation, contending that it includes four incorrect conclusions of law. The Court disagrees for the following reasons. First, Aurobindo argues that the Report inco rrectly determines that Aurobindo failed to raise a substantial question regarding noninfringeme nt of the ’992 and ’616 patents.
Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error